Lou Gehrig's Treatment Also Slows Melanoma Growth

Riluzole, an FDA-approved drug for Lou Gehrig's Disease has been shown to slow the growth of melanoma. A phase 0 (first in human) trial on people with late stages of melanoma conducted by investigators at Rutgers shows that Riluzole slowed the growth of melanoma in enough patients to warrant further studies.